Stents, scaffolds and DCB

This live case–based session explores how innovation is shaping structural heart and coronary interventions.

A real-time TAVI case in a degenerated aortic valve highlights pre-procedural imaging, sizing strategies, procedural decision-making, and post-procedural care.

The session also reviews ongoing and upcoming Myval THV trials, showing how new technologies impact...

A 60-year-old male with hypertension, type II diabetes, and moderately impaired LV function (45%), has a history of LAD PCI treated with three Cypher stents in 2006. He underwent further treatment for LAD in-stent restenosis in 2012, 2020, and 2022 using a new stent and DCB....

This session presents a comprehensive exploration of vascular interventions, highlighting advanced techniques such as retrograde tibial artery approaches for long CTO lesions in the superficial femoral artery, catheter-directed thrombectomy for bilateral pulmonary embolism, and innovative endovascular management of pulmonary haemorrhages in Eisenmenger syndrome. Case reports and...

This session looks beyond trial data to examine how the SELUTION DeNovo study may reshape PCI practice in real-world settings.

The discussion reviews key clinical results from this large-scale DeNovo PCI trial and explains the technology behind the SELUTION SLR drug-eluting balloon, including its slow-flow drug delivery...

Guillaume Bonnet interviews Christian Spaulding about the SELUTION DeNovo Trial he presented at TCT 2025, in San Francisco. 

Prof. Christian Spaulding, principal investigator of the study, discusses the trial design, key outcomes, breaks down the nuances behind the sirolimus DCB strategy versus contemporary DES, and shares insights...

This individual patient data analysis of the three largest RCTs evaluating IVUS-guided stent optimisation showed that an MSA > 5.5 mm2 was associated with reduced TVF at one year. 

Alessandro Sticchi provides us with a curated overview of the late-breaking trials he found most relevant for interventional cardiologists from AHA 2025.

The PCR Trials Book provides updates on the latest randomised clinical trials of relevance to practicing interventional cardiologists in the field of coronary, valvular and structural interventions. Each trial, selected by the Editors, has been synthesised in order to provide you with a concise overview. View a...

The SELUTION DeNovo trial, presented by Christian Spaulding at TCT 2025, delivers the first head-to-head comparison between a sirolimus DCB strategy and contemporary DES in PCI.

In this review, Salvatore Brugaletta breaks down the 1-year results and what these findings truly mean for everyday lesion-by-lesion decision-making.

Ali Nazmi Calik provides his take on the OCVC-BIF study presented by Takayuki Ishihara at TCT 2025, in San Francisco.